| Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFE) |
80 |
| Conjunctivitis in dupilumab clinical trials |
61 |
| Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis |
54 |
| Deep-learning-based, computer-aided classifier developed with a small dataset of clinical images surpasses board-certified dermatologists in skin tumour diagnosis |
47 |
| Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa |
34 |
| Efficacy and safety of topical JTE- a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: a phase II, multicentre, randomized, vehicle-controlled clinical study |
26 |
| Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement |
25 |
| Efficacy and adverse events of oral isotretinoin for acne: a systematic review |
25 |
| Alopecia areata: a review of disease pathogenesis |
25 |
| A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process |
25 |
| Phase III randomized study of the proposed adalimumab biosimilar GP2017 in psoriasis: impact of multiple switches |
25 |
| Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double-blinded, controlled studies (UNCOVER- UNCOVER- UNCOVER-3) |
23 |
| Atopic dermatitis: the skin barrier and beyond |
23 |
| Incidence and prevalence of rosacea: a systematic review and meta-analysis |
22 |
| Symptoms and diagnosis of anxiety and depression in atopic dermatitis in US adults |
22 |
| Wet work exposure and hand eczema among healthcare workers: a cross-sectional study |
22 |
| Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis |
22 |
| Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis |
21 |
| Sunscreen photoprotection and vitamin D status |
20 |
| Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative) |
20 |
| Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32-week results from the randomized placebo-controlled TRANSFIGURE trial |
19 |
| Interleukin-36 in hidradenitis suppurativa: evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop |
18 |
| Epidemiology of basal and cutaneous squamous cell carcinoma in the UK 2013-15: a cohort study |
18 |
| The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: results from a randomized double-blind placebo-controlled study |
18 |
| British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018 |
17 |
| Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study |
17 |
| Incidence of hidradenitis suppurativa among tobacco smokers: a population-based retrospective analysis in the USA |
17 |
| Demodex mites modulate sebocyte immune reaction: possible role in the pathogenesis of rosacea |
17 |
| Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments |
17 |
| Risk of cancer in patients with psoriasis on biological therapies: a systematic review |
16 |
| The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients |
16 |
| Efficacy and safety of the Janus kinase 1 inhibitor PF-04965842 in patients with moderate-to-serve psoriasis: phase II, randomized, double-blind, placebo-controlled study |
15 |
| The genetic basis for most patients with pustular skin disease remains elusive |
15 |
| Transepidermal water loss in healthy adults: a systematic review and meta-analysis update |
15 |
| Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a randomized, placebo-controlled clinical trial |
15 |
| Efficacy and safety of continuous every-2-week dosing of ixekizumab over 52 weeks in patients with moderate-to-severe plaque psoriasis in a randomized phase III trial (IXORA-P) |
15 |
| The effect of sunscreen on vitamin D: a review |
14 |
| Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis? |
14 |
| Proposal of a new scoring formula for the Dermatology Life Quality Index in psoriasis |
13 |
| Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study |
13 |
| HLA-Cw6 and psoriasis |
13 |
| Diagnostic accuracy of ex vivo fluorescence confocal microscopy in Mohs surgery of basal cell carcinomas: a prospective study on 753 margins |
13 |
| Paracrine regulation of melanogenesis |
13 |
| A multidimensional assessment of the burden of psoriasis: results from a multinational dermatologist and patient survey |
13 |
| Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and II |
13 |
| Epithelial barrier dysfunctions in atopic dermatitis: a skin-gut-lung model linking microbiome alteration and immune dysregulation |
13 |
| Prevalence of skin disease in a population-based sample of adults from five European countries |
13 |
| Synergistic effects of long-wavelength ultraviolet A1 and visible light on pigmentation and erythema |
13 |
| Early-life regional and temporal variation in filaggrin-derived natural moisturizing factor, filaggrin-processing enzyme activity, corneocyte phenotypes and plasmin activity: implications for atopic dermatitis |
13 |
| Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients |
13 |
